EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Profiling of Circulating Cell-free DNA Methylation Patterns Identifies Aberrant Methylated CTBP1 Promotor Sites for Prediction of Alzheimer’s Disease

Zhiwu Dong, Kewen Zhao, Hongjun Gu, Wenwei Yang, Xin Zhang

Journal of Integrative Neuroscience · 2025

DOI: 10.31083/jin36527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, 2025. Verfasst von Zhiwu Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Shanghai Second People's Hospital, 200011 Shanghai, China. Hauptthemen laut MEDLINE: DNA Methylation, Alzheimer Disease, DNA-Binding Proteins, Alcohol Oxidoreductases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipal Science and Technology Commission, project from Shanghai Jinshan District Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer’s disease (AD) is the most common neurodegenerative disease affecting the elderly, with its diagnosis at early stages crucial for effective intervention. Recent evidence increasingly supports the role of epigenetic alterations in AD pathogenesis, highlighting the need for innovative biomarkers that reflect these changes. This study aimed to characterize the genome-wide DNA methylation profiles of cell-free DNA in peripheral blood for potential biomarkers associated with AD.

Methods

The Illumina Infinium array was utilized to detect the methylation patterns of circulating cell-free DNA from AD patients and healthy controls. The R Bioconductor Linear Models for Microarray Data (LIMMA) package was employed to identify methylation variable positions (MVPs), and Probe Lasso was used to pinpoint differentially methylated regions (DMRs) linked to AD. Bioinformatics enrichment analysis of the annotated genes was performed using EnrichR. A second cohort was recruited to validate the methylation changes at the C-terminal binding protein1 (CTBP1) promoter cytosine-phosphate-guanine (CpG) sites via pyrosequencing. Additionally, microarray data from the Gene Expression Omnibus (GEO) database were analyzed to further validate gene expression and immune infiltration.

Results

A unique DNA methylation landscape in peripheral blood was characterized for AD patients and 4335 MVPs showed significant differential methylation (p < 0.01). Functional annotation and pathway enrichment analysis underscored processes and pathways inherent in the nervous system. Probe Lasso identified 68 DMRs annotated to 10 genes, with hypermethylation of CpG islands in the CTBP1 TSS1500 promoter showing significant differences when AD and controls were compared (p < 0.01), with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.779. Analysis of immune cell infiltration revealed CTBP1 expression is significantly correlated with altered distribution of immune cells (p < 0.001), underscoring its potential role in modulating immune responses in AD. Moreover, CTBP1 expression levels significantly varied across multiple GEO datasets.

Conclusions

AD displays distinct DNA methylation patterns in peripheral blood and CTBP1 promoter hypermethylation represents a promising potential biomarker for AD diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationAlzheimer DiseaseDNA-Binding ProteinsAlcohol OxidoreductasesCell-Free Nucleic AcidsHumansAgedMaleFemaleBiomarkersAged, 80 and overPromoter Regions, GeneticEpigenesis, Genetic

Stichwörter der Autor:innen

Alzheimer’s diseaseDNA methylationbiomarkerepigeneticspyrosequencing

Substanzen

DNA-Binding ProteinsAlcohol OxidoreductasesC-terminal binding proteinBiomarkersCell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Shanghai Second People's Hospital, 200011 Shanghai, China.
  • Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Department of Geriatric Medicine, Shanghai Jinshan District Hospital of Integrated Traditional Chinese and Western Medicine, 201501 Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai Municipal Science and Technology Commission
  • project from Shanghai Jinshan District Health Commission
  • Professional Training Program from Shanghai Huangpu District Health Commission

Zitieren

APA

Dong, Z., Zhao, K., Gu, H., Yang, W., & Zhang, X. (2025). Profiling of Circulating Cell-free DNA Methylation Patterns Identifies Aberrant Methylated CTBP1 Promotor Sites for Prediction of Alzheimer’s Disease. Journal of Integrative Neuroscience. https://doi.org/10.31083/jin36527

Vancouver

Dong Z, Zhao K, Gu H, Yang W, Zhang X. Profiling of Circulating Cell-free DNA Methylation Patterns Identifies Aberrant Methylated CTBP1 Promotor Sites for Prediction of Alzheimer’s Disease. Journal of Integrative Neuroscience. 2025. doi:10.31083/jin36527

BibTeX
@article{Dong2025,
  author = {Dong, Zhiwu and Zhao, Kewen and Gu, Hongjun and Yang, Wenwei and Zhang, Xin},
  title = {Profiling of Circulating Cell-free DNA Methylation Patterns Identifies Aberrant Methylated CTBP1 Promotor Sites for Prediction of Alzheimer’s Disease},
  journal = {Journal of Integrative Neuroscience},
  year = {2025},
  doi = {10.31083/jin36527}
}
Kostenlos starten →